Please try another search
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Name | Age | Since | Title |
---|---|---|---|
Georges E. Morin | - | 2020 | Independent Director |
Philip R. Renaud | - | 2010 | Vice Chairman |
Marc Edwards | - | 2016 | President, CEO & Director |
Rashieda Gluck | - | 2018 | Member of Scientific Advisory Board |
Gordon Guay | - | 2018 | Chairman of Scientific Advisory Board |
Robert B. Huizinga | 58 | 2018 | Executive Chairman & Member of Scientific Advisory Board |
John Coleman | - | 2023 | Director |
Gregory S. Schultz | 74 | 2022 | Chief Scientific Officer & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review